Reperfusion therapy for ST elevation acute myocardial infarction in yemen. description of the current situation. data from gulf registry of acute coronary events ( The Gulf RACE-I)

Yemen, one of the countries participating in Gulf Registry of Acute Coronary Events (RACE) [1,2], has limited resources with no program of primary PCI yet. Gulf RACE-I is a prospective,multinational,multicenter survey of consecutive patients hospitalized with the final diagnosis of acute coronary syndrome (ACS) in six Arabian Peninsula/Gulf countries over a period of 6 months. Details on the survey were previously published [1,2].We refer the Gulf RACE data regarding Yemeni patients with ST elevation myocardial infarction (STEMI) aiming to highlight the characteristics of STEMI among Yemeni patients, predisposing risk factors, type and rate of reperfusion therapy, and cardiac mortality rate. Primary end-point of the present studywas to assess the incidence of in-hospital, 1-month and 1-year cardiac mortality. The in-hospital occurrence of cardiogenic shock, malignant arrhythmias and congestive heart failure was also collected. Vital status was monitored by means of a phone contact at 1-month and at 1-year follow-up. All management decisions were at the discretion of the treating physician. The study received ethical approval from the institutional ethical bodies in the Ministry of Health in Yemen.